Grant of 9,00,000 Stock Options Under ESOP Scheme 2026

The Nomination & Remuneration Committee approved the grant of 9,00,000 stock options to eligible employees under ESOP Scheme 2026, effective September 29, 2026.

Tue 29 Sep 2026

Stock options granted

9,00,000

Shareholder-approved limit

33,00,000 options

Face value per share

Rs. 1/-

Exercise price discount

Not exceeding 50% of one-year average market price

Lock-in period

One (1) year from allotment

What was announced

The Nomination and Remuneration Committee (NRC), by a circular resolution passed on September 29, 2026, approved the grant of 9,00,000 (Nine Lakh) stock options to eligible employees under the Mangalam Global Enterprise Limited ESOP Scheme 2026.

Key details

• Options granted: 9,00,000
• Within shareholder-approved limit of 33,00,000 options
• Shares covered: 9,00,000 equity shares of face value Rs. 1/- each
• Effective date of grant: September 29, 2026

Pricing

The exercise price is to be determined by the NRC for each grant, at a discount not exceeding 50% of the Average Market Price (closing price on the exchange with the highest trading volume) of the shares for one year, taken one day prior to the grant date.

Other terms

• Each vested option entitles the holder to one equity share on payment of the exercise price and applicable taxes.
• Vesting follows the schedule and conditions set by the NRC at the time of grant.
• Shares allotted are locked in for one (1) year from the date of allotment or credit to the grantee's demat account, during which they cannot be sold, transferred or encumbered.
• The scheme is stated to be in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

How to read it

ESOPs are a way of linking employee rewards to the company's shares. At the grant stage no shares are issued, so there is no immediate change in share count. If and when options vest and are exercised, new equity shares would be issued, which adds to the total shares outstanding. Options vested, exercised, lapsed and diluted EPS are shown as not applicable at this grant stage.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.